Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JMA Opposed to Performance-Oriented Medical Fees
August 4, 2008
- R&D NEWS IN BRIEF
August 4, 2008
- Majority of People Have a Bad Image of Morphine: Palliative Care Survey
August 4, 2008
- Asahi Kasei to Enter Market for Advanced Medical Devices
July 28, 2008
- Nichi-Iko Aims at Becoming World Top-10 Generic Maker
July 28, 2008
- GENERICS NEWS IN BRIEF
July 28, 2008
- Korosho Announces Drug Dispensing Fees per Prescription for the First Time
July 28, 2008
- Sawai to Focus on Drugs for Lifestyle Diseases
July 28, 2008
- TOPICS 2 articles
July 28, 2008
- R&D NEWS IN BRIEF
July 28, 2008
- Vildagliptin More Effective than Voglibose
July 28, 2008
- REGULATORY NEWS IN BRIEF －２－
July 28, 2008
- REGULATORY NEWS IN BRIEF －１－
July 28, 2008
- Korosho Requires Makers of MTX to Take New Measures to Prevent Overdosing
July 28, 2008
- BUSINESS NEWS IN BRIEF
July 28, 2008
- Korosho Shows Interest in GPOs of the US
July 28, 2008
- JPLA SEMINAR
July 28, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 28, 2008
- Average Wage Hike \5,949 in 2008
July 28, 2008
- Gefitinib Beneficial for Adenocarcinoma Regardless of Smoking History
July 28, 2008
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…